Effects of halothane on coronary and systemic circulations, myocardial metabolism and blood flow distribution within the canine heart. 1977

T Saito, and K Okazaki, and S Sakata, and S R Tonogai, and Y Tanaka, and K Takata, and M Asai, and F Matsuda, and Y Yamada, and T Tomino, and Y Tomino

Myocardial metabolism, blood flow distribution within the heart, and coronary and systemic circulations were observed during halothane anesthesia using 15 mongrel dogs. Pao2 and Paco2 were maintained near 100 and 40 torr respectively throughout the study. As arterial halothane content increased, most parameters of systemic circulation were depressed significantly. Coronary blood flow was reduced in parallel with myocardial oxygen consumption (MVo2) (r=+0.89, pless than0.001). Myocardial contractility decreased significantly as anesthesia deepened. MVo2 and myocardial CO2 production were reduced as arterial halothane concentration rose. Arterial-coronary venous difference in blood oxygen content remained unchanged even in deep stage. Lactate and pyruvate were continuously taken up by the myocardium, although the amounts of uptake were reduced as anesthesia progressed. Calculated excess lactate and redox potential did not show any signs of myocardial hypoxia even in deep halothane anesthesia. Among major hemodynamic parameters, left ventricular dp/dt max showed the closest correlation with MVo2. Microsphere injection method was used to observe blood flow distribution within the heart. Halothane did not influence the distribution significantly and I/O ratio of the left ventricular free wall remained near 1.0 during the study.

UI MeSH Term Description Entries
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D001783 Blood Flow Velocity A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. Blood Flow Velocities,Flow Velocities, Blood,Flow Velocity, Blood,Velocities, Blood Flow,Velocity, Blood Flow
D002245 Carbon Dioxide A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. Carbonic Anhydride,Anhydride, Carbonic,Dioxide, Carbon
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006221 Halothane A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178) 1,1,1-Trifluoro-2-Chloro-2-Bromoethane,Fluothane,Ftorotan,Narcotan

Related Publications

T Saito, and K Okazaki, and S Sakata, and S R Tonogai, and Y Tanaka, and K Takata, and M Asai, and F Matsuda, and Y Yamada, and T Tomino, and Y Tomino
June 1979, The Journal of thoracic and cardiovascular surgery,
T Saito, and K Okazaki, and S Sakata, and S R Tonogai, and Y Tanaka, and K Takata, and M Asai, and F Matsuda, and Y Yamada, and T Tomino, and Y Tomino
February 1991, Masui. The Japanese journal of anesthesiology,
T Saito, and K Okazaki, and S Sakata, and S R Tonogai, and Y Tanaka, and K Takata, and M Asai, and F Matsuda, and Y Yamada, and T Tomino, and Y Tomino
August 1970, British journal of anaesthesia,
T Saito, and K Okazaki, and S Sakata, and S R Tonogai, and Y Tanaka, and K Takata, and M Asai, and F Matsuda, and Y Yamada, and T Tomino, and Y Tomino
July 1971, British journal of anaesthesia,
T Saito, and K Okazaki, and S Sakata, and S R Tonogai, and Y Tanaka, and K Takata, and M Asai, and F Matsuda, and Y Yamada, and T Tomino, and Y Tomino
January 1988, Anesthesiology,
T Saito, and K Okazaki, and S Sakata, and S R Tonogai, and Y Tanaka, and K Takata, and M Asai, and F Matsuda, and Y Yamada, and T Tomino, and Y Tomino
July 1969, Anesthesiology,
T Saito, and K Okazaki, and S Sakata, and S R Tonogai, and Y Tanaka, and K Takata, and M Asai, and F Matsuda, and Y Yamada, and T Tomino, and Y Tomino
January 1989, Canadian journal of anaesthesia = Journal canadien d'anesthesie,
T Saito, and K Okazaki, and S Sakata, and S R Tonogai, and Y Tanaka, and K Takata, and M Asai, and F Matsuda, and Y Yamada, and T Tomino, and Y Tomino
February 1995, Anesthesia and analgesia,
T Saito, and K Okazaki, and S Sakata, and S R Tonogai, and Y Tanaka, and K Takata, and M Asai, and F Matsuda, and Y Yamada, and T Tomino, and Y Tomino
February 1981, The Journal of pharmacology and experimental therapeutics,
T Saito, and K Okazaki, and S Sakata, and S R Tonogai, and Y Tanaka, and K Takata, and M Asai, and F Matsuda, and Y Yamada, and T Tomino, and Y Tomino
December 1978, The Tokushima journal of experimental medicine,
Copied contents to your clipboard!